Studies of microbiome alterations and GLP-1 release are inconclusive, but may be more impactful when including both prebiotics and probiotics
Subsequently, other drugs such as Novos Victoza (liraglutide, approved in 2010), AstraZenecas Bydureon (exenatide, 2012), GSKs Tanzeum (albiglutide, 2014), Lillys Trulicity (dulaglutide, 2014) and Novos Ozempic (semaglutide, 2017) and Rybelsus (oral semaglutide, 2019) were approved
Retatrutide is not referenced in any current NICE guidance, as it has not received regulatory approval
Occupational risk in knee osteoarthritis: a systematic review and meta-analysis of observational studies
Learn more A meat-free, plant-packed meal plan that delivers hunger-busting protein from beans, soy, eggs and dairy
You'll receive detailed doctor notes in simple language explaining what your glutathione levels mean for your immune function, cellular protection, and detoxification capacity